المؤلفون: Julia K. Tietze, Ralf Gutzmer, Claus Garbe, Lucie Heinzerling, Jessica C. Hassel, Anja Gesierich, Andrea Forschner, Friedegund Meier, Michael C. Kirchberger, Lisa Zimmer, Carmen Loquai, Ursula Dietrich, Carsten Weishaupt, Reinhard Dummer, Ioannis Thomas, Renate Ursula Wahl, Simone M. Goldinger, Martin Leverkus, Dirk Schadendorf, Carola Berking, Jochen Utikal, Thomas Eigentler, Angela M. Krackhardt, Lars Hofmann, Daniela Göppner, Selma Ugurel, Gerold Schuler, Maria I. Schmidgen

المساهمون: University of Zurich, Heinzerling, Lucie M

المصدر: European Journal of Cancer. 60:210-225

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Eye Diseases, Heart Diseases, Programmed Cell Death 1 Receptor, Respiratory Tract Diseases, Medizin, 610 Medicine & health, Antineoplastic Agents, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, 1306 Cancer Research, Musculoskeletal Diseases, Adverse effect, Melanoma, Aged, Retrospective Studies, business.industry, 10177 Dermatology Clinic, Antibodies, Monoclonal, Cancer, Cell Cycle Checkpoints, Middle Aged, medicine.disease, Myasthenia gravis, Nivolumab, 030220 oncology & carcinogenesis, Immunology, 2730 Oncology, Female, Nervous System Diseases, Skin cancer, business, 030217 neurology & neurosurgery, medicine.drug

وصف الملف: 657_Zimmer L. et al._Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD1 Therapy_EJC 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1556fdca6ff1cf1a91650c07c15aefTest
https://doi.org/10.1016/j.ejca.2016.02.024Test

المؤلفون: Jörg Trojan, Lucie Heinzerling, Victor Grünwald, Lisa Zimmer, Niels Reinmuth, Marc-Oliver Grimm, Oliver Bähr, Jessica C. Hassel, Thomas Eigentler, Jan Leipe, Ralf Gutzmer, Julia K. Tietze, Jens Aberle

المصدر: Cancer treatment reviews. 57

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, Pharmacology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, CTLA-4 Antigen, Melanoma, business.industry, Cancer, Antibodies, Monoclonal, General Medicine, Immunotherapy, medicine.disease, Immune checkpoint, Blockade, 030104 developmental biology, Nivolumab, Methylprednisolone, 030220 oncology & carcinogenesis, business, Adverse drug reaction, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87ec2049804c88f517be79f732e117cbTest
https://pubmed.ncbi.nlm.nih.gov/28550712Test

المؤلفون: Jochen Utikal, Jessica C. Hassel, Daniela Göppner, Martin Leverkus, Maria I. Schmidgen, Reinhard Dummer, Thomas Eigentler, Carola Berking, Anja Gesierich, Lisa Zimmer, Ursula Dietrich, Andrea Forschner, Angela M. Krackhardt, Friedegund Meier, Gerold Schuler, Carsten Weishaupt, Ioannis Thomas, Simone M. Goldinger, Ralf Gutzmer, Claus Garbe, Selma Ugurel, Dirk Schadendorf, Carmen Loquai, Lars Hofmann, Lucie Heinzerling, Renate Ursula Wahl, Julia K. Tietze, Michael C. Kirchberger

المصدر: European journal of cancer (Oxford, England : 1990). 60

مصطلحات موضوعية: 0301 basic medicine, Adult, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Gastrointestinal Diseases, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, Antineoplastic Agents, Pembrolizumab, Antibodies, Monoclonal, Humanized, Endocrine System Diseases, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Endocrine system, Medicine, Humans, Melanoma, Aged, Retrospective Studies, Gastrointestinal tract, business.industry, Cancer, Antibodies, Monoclonal, Middle Aged, medicine.disease, 030104 developmental biology, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Immunology, Female, Kidney Diseases, Drug Eruptions, Skin cancer, Chemical and Drug Induced Liver Injury, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::263bce5158d70c2cbeead10f02368ef9Test
https://pubmed.ncbi.nlm.nih.gov/27085692Test